Coherus Oncology, Inc. (CHRS) AI Dilution Summary

Cash was $105,306,000 at 2026-06-30 against estimated monthly burn of $20,696,667. On 2026-08-14 the company drew the full $55,000,000 Tranche A senior secured term loan, and used part of it to repay the prior 2029 Term Loan. Dilution here is driven primarily by the at-the-market program with Leerink Partners LLC, authorised to $50,000,000.